← FDA Drug Approvals (Drugs@FDA)

ZEMDRI

NDA · New Drug Application · Sponsor: CIPLA USA · Approved 2018-06-25

Drug application

FDA Application #

NDA210303

Application type

New Drug Application

Brand name

ZEMDRI

Generic name

PLAZOMICIN

Active ingredients

PLAZOMICIN SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CIPLA USA

Manufacturer

Cipla Therapeutics Inc.

First approval

2018-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown